Frederik Hvid‐Jensen

Incidence of Adenocarcinoma among Patients with Barrett's Esophagus

Frederik Hvid‐Jensen, Lars Pedersen, Asbjørn Mohr Drewes et al. · New England Journal of Medicine · 2011 · 1.4K citations · Full text

Medicine, Oncology, Pathology +17

Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain

Anne Lund Krarup, Lars Ny, Jenny Gunnarsson et al. · Scandinavian Journal of Gastroenterology · 2013 · 154 citations

Medicine, Pharmacotherapy, Gastroenterology +16

Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain

Anne Lund Krarup, Lars Ny, Magnus Åstrand et al. · Alimentary Pharmacology & Therapeutics · 2011 · 135 citations

Medicine, Pharmacology, Pharmacotherapy +11

Proton pump inhibitor use may not prevent high‐grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients

Frederik Hvid‐Jensen, Lars Henning Pedersen, Peter Funch‐Jensen et al. · Alimentary Pharmacology & Therapeutics · 2014 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting

Frederik Hvid‐Jensen, Lars Kjelsberg Pedersen, Rikke Linnemann Nielsen et al. · Clinical Epidemiology · 2013 · 36 citations · Full text

Public Health, Health Behavior, Pharmacotherapy +16